Details of the Drug Combinations

General Information of This Drug (ID: DM1MBYQ)

Drug Name

Ganciclovir DM1MBYQ

Synonyms

ganciclovir; 82410-32-0; Gancyclovir; Cytovene; Vitrasert; Hydroxyacyclovir; Ganciclovirum; Zirgan; RS-21592; Cymevene; HHEMG; Biolf 62; BW-759U; Ganciclovirum [Latin]; 2'-NDG; 2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1H-purin-6(9H)-one; BW 759U; BIOLF-62; 2'-Nor-2'-deoxyguanosine; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BW-B 759U; UNII-P9G3CKZ4P5; DRG-0018; BW 759; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; CCRIS 9212; GA2; Cytovene-IV; HSDB 6512

Indication

Disease Entry	ICD 11	Status	REF
Cytomegalovirus infection	1D82	Approved	[1]
Cytomegalovirus retinitis	9B72.00	Approved	[1]
Virus infection	1A24-1D9Z	Approved	[2]
Radiculitis	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Antiviral Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Ganciclovir + ISIS 2922	DCYURY8	ISIS 2922	Virus infection (Cell Line: .)	[3]
------------------------------------------------------------------------------------

References

1	Ganciclovir FDA Label
2	Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
3	Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.